Article
SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
14 Apr 2022
Abstract excerpt
Serine-rich splicing factor3 (SRSF3) plays an essential role in cell proliferation and inducing and maintaining of cancers as a proto-oncogene. However, the mechanisms of SRSF3 in pan-cancers are still unknown. In our study, a visualized prognostic landscape of SRSF3 in pan-cancer was investigated and the relationship between SRSF3 expression and immune infiltration was also investigated. The expression pattern...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
